111 related articles for article (PubMed ID: 8620458)
1. Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C.
Hoelting T; Duh QY; Clark OH; Herfarth C
Cancer Lett; 1996 Feb; 100(1-2):89-93. PubMed ID: 8620458
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
Hoelting T; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
Hoelting T; Duh QY; Clark OH; Herfarth C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
[TBL] [Abstract][Full Text] [Related]
4. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
[TBL] [Abstract][Full Text] [Related]
5. Invasion of metastatic human follicular thyroid cancer is inhibited via antagonism of protein kinase C.
Hoelting T; Duh QY; Clark OH; Herfarth C
Cancer Lett; 1997 Oct; 119(1):1-5. PubMed ID: 18372514
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Biochem Biophys Res Commun; 1993 Sep; 195(3):1230-6. PubMed ID: 8216254
[TBL] [Abstract][Full Text] [Related]
7. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.
Hoelting T; Zielke A; Siperstein AE; Clark OH; Duh QY
Clin Exp Metastasis; 1994 Jul; 12(4):315-23. PubMed ID: 8039305
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
Baltuch GH; Couldwell WT; Villemure JG; Yong VW
Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells.
Gundimeda U; Chen ZH; Gopalakrishna R
J Biol Chem; 1996 Jun; 271(23):13504-14. PubMed ID: 8662863
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway.
Simard M; Zhang W; Hinton DR; Chen TC; Weiss MH; Su YZ; Gopalakrishna R; Law RE; Couldwell WT
Cancer Lett; 2002 Nov; 185(2):131-8. PubMed ID: 12169386
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination.
Guthrie N; Gapor A; Chambers AF; Carroll KK
J Nutr; 1997 Mar; 127(3):544S-548S. PubMed ID: 9082043
[TBL] [Abstract][Full Text] [Related]
13. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
Shen F; Xue X; Weber G
Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
[TBL] [Abstract][Full Text] [Related]
15. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines.
Kishino T; Watanabe M; Kimura M; Sugawara I
Biol Pharm Bull; 1997 Dec; 20(12):1257-60. PubMed ID: 9448099
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen inhibits hepatoma cell growth through an estrogen receptor independent mechanism.
Jiang SY; Shyu RY; Yeh MY; Jordan VC
J Hepatol; 1995 Dec; 23(6):712-9. PubMed ID: 8750171
[TBL] [Abstract][Full Text] [Related]
19. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles.
Kraiem Z; Sadeh O; Yosef M; Aharon A
Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292
[TBL] [Abstract][Full Text] [Related]
20. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action.
Banu KS; Govindarajulu P; Aruldhas MM
Endocr Pathol; 2001; 12(3):315-27. PubMed ID: 11740053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
